Table 1 Baseline demographics of the study group

Age (years)

61.34 ± 11.34

66.57 ± 8.38

0.01

Gender (M/F)

41/30

43/25

0.51

Skin AF (A.U.)

1.90 ± 0.27

2.71 ± 0.31

0.01

BMI (kg/m²)

26.50 ± 3.86

26.05 ± 3.25

0.74

SBP (mmHg)

142.36 ± 14.83

139.06 ± 16.81

0.22

DBP (mmHg)

80.80 ± 13.57

75.41 ± 9.46

0.01

PP (mmHg)

61.92 ± 12.70

63.94 ± 14.64

0.39

Hypertension, n (%)

59 (83.10)

57 (83.82)

0.91

DM, n (%)

0.06

 None, n (%)

50 (70.42)

40 (58.82)

 OHA, n (%)

20 (28.17)

21 (30.88)

 RI, n (%)

1 (1.41)

7 (10.29)

Hyperlipidemia, n (%)

57 (80.28)

52 (76.47)

0.59

Stroke, n (%)

3 (4.23)

7 (10.29)

0.17

IHD, n (%)

9 (12.68)

21 (30.88)

0.01

PAOD, n (%)

1 (1.41)

1 (1.47)

0.98

eGFR (mL/min/1.73 m²)

66.64 ± 17.77

62.06 ± 22.73

0.19

Antiplatelets, n (%)

48 (67.61)

43 (63.24)

0.59

β-Blockers, n (%)

25 (35.21)

34 (50.00)

0.08

CCBs, n (%)

29 (40.85)

33 (48.53)

0.36

ACEIs/ARBs, n (%)

49 (69.01)

43 (63.24)

0.47

Statins, n (%)

40 (56.34)

41 (60.29)

0.64

Smoking

0.06

 Never, n (%)

55 (77.46)

40 (58.82)

 Ever, n (%)

10 (14.08)

19 (27.94)

 Active, n (%)

6 (8.45)

9 (13.24)